Related Experiment Video
Updated: Jun 18, 2026

09:54
A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
Cardiac adaptive responses after hypoxia in an experimental model
Ismaeel Bin-Jaliah1, Hania I Ammar, Dimitri P Mikhailidis
1Department of Physiology, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Angiology
|November 27, 2009
Summary
Acute intermittent hypoxia (AIH) preconditioning enhances heart function by increasing vascular endothelial growth factor (VEGF) and erythropoietin (EPO). This study shows AIH boosts endogenous cardioprotective mechanisms, offering a novel approach for cardiac protection.
Area of Science:
- Cardiovascular Physiology
- Molecular Biology
- Hypoxia Research
Background:
- Hypoxic preconditioning is a known cardioprotective strategy.
- The specific roles of VEGF and EPO in acute intermittent hypoxia (AIH) remain to be fully elucidated.
- Understanding these pathways can lead to novel therapeutic interventions.
Purpose of the Study:
- To investigate the role of vascular endothelial growth factor (VEGF) and erythropoietin (EPO) in mediating cardioprotection induced by AIH.
- To assess the functional recovery of the heart after ischemia-reperfusion following AIH exposure.
- To examine the expression levels of VEGF and EPO post-AIH.
Main Methods:
- Male Wistar rats were exposed to normoxia (Nx) or AIH (cycles of hypoxia/reoxygenation).
- Isolated hearts were subjected to in vitro global ischemia followed by reperfusion.
- Hemodynamic parameters including left ventricular developed pressure (LVDP), rate pressure product (RPP), and peak pressure rise were measured.
Main Results:
- Hearts from AIH-exposed rats showed significantly improved LVDP, RPP, and peak pressure rise compared to normoxic controls.
- Expression of VEGF and EPO was significantly upregulated at 3, 8, and 24 hours after AIH.
- AIH significantly enhanced cardiac function post-ischemia-reperfusion.
Conclusions:
- AIH acts as a potent preconditioning stimulus, enhancing endogenous cardioprotective mechanisms.
- Increased expression of VEGF and EPO likely mediates the observed cardioprotective effects of AIH.
- Hypoxic training presents a promising strategy for improving cardiac resilience.
Related Concept Videos
Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
